Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 10
EC Number Crystallization (Commentary) Reference
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3- 485757, 485758
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3ATIC complex crystallized in monoclinic space group P2(1), a = 56.48 A, b = 107.88 A, c = 103.86 A and beta = 91.2° 485746, 485755, 485759, 485760
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3crystal structure analysis of human enzyme complexed with the sulfamido-bridged N-[(S)-(4-([(2-amino-4-hydroxy-quinazolin-6-yl)dihydroxy-lambda-4-sulfanyl]amino)phenyl)-hydroxymethyl]-L-glutamic acid at 2.55 A resolution, PDB ID 1P4R 736619
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3crystallized in a binary complex with methotrexate, single crystal at 96 K to 2.3 A resolution, monoclinic crystals, space group P2(1), with unit-cell dimensions a = 65.17, B = 105.93, c= 103.47 A, beta = 108.27 degrees 485755
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3crystallized in complex with its inhibitor 2-[5-hydroxy-3-methyl-1-(2-methyl-4-sulfophenyl)-1H-pyrazo]-4-sulfobenzoic acid 659419
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3purified recombinant His-tagged enzyme free or in complex with substrate 5-aminoimidazole-4-carboxamide ribonucleotide, both with adventitiously active site-bound nucleotide inhibitor of the cyclohydrolase activity, X-ray diffraction structure determination and analysis at 2.5 A and 2.2 A resolution, respectively 719985
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3purified recombinant His6-tagged PurH, without methylation of the 28 lysine residues, sitting drop vapour diffusion method, mixing of 0.001 ml of 56 mg/ml protein in 0.8 M sodium/potassium hydrogen phosphate, pH 7.5, with 0.001 ml of reservoir solution containing 0.1 M sodium acetate, pH 5.0, 1 M ammonium sulfate, 1 week to 1 month, X-ray diffraction structure determination and analysis at 3.05 A resolution 718506
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3recombinant His-tag fusion protein crystallized by sitting drop vapor diffusion method in complex with its inhibitor beta-DADF 657946
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3sitting drop vapor diffusion method, co-crystallized in the presence of substrate with BW1540 and BW2315 652530
Show all pathways known for 2.1.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.1.2.3the three-dimensional structure of TM1249 is determined to 1.88 A resolution by molecular replacement 689976
Results 1 - 10 of 10